Publications by authors named "K Cleal"

Article Synopsis
  • Telomerase is usually how our cells keep their ends (telomeres) healthy, but about 15% of cancers use a different method called ALT which can create different lengths of telomeres.
  • A gene called ATRX often doesn't work properly in ALT cancers, and when ATRX is lost, it can kickstart the ALT process, making cells live longer.
  • In some cancer cells, while there is a temporary boost in telomere length due to losing ATRX, the telomeres eventually get shorter again, leading to cell death or changes in how they grow.
View Article and Find Full Text PDF

DNA polymerase theta (POLQ) is a principal component of the alternative non-homologous end-joining (ANHEJ) DNA repair pathway that ligates DNA double-strand breaks. Utilizing independent models of POLQ insufficiency during telomere-driven crisis, we found that  cells are resistant to crisis-induced growth deceleration despite sustaining inter-chromosomal telomere fusion frequencies equivalent to wild-type (WT) cells. We recorded longer telomeres in than WT cells pre- and post-crisis, notwithstanding elevated total telomere erosion and fusion rates.

View Article and Find Full Text PDF

Structural variation (SV) plays a fundamental role in genome evolution and can underlie inherited or acquired diseases such as cancer. Long-read sequencing technologies have led to improvements in the characterization of structural variants (SVs), although paired-end sequencing offers better scalability. Here, we present dysgu, which calls SVs or indels using paired-end or long reads.

View Article and Find Full Text PDF

Telomere biology disorders are complex clinical conditions that arise due to mutations in genes required for telomere maintenance. Telomere length has been utilised as part of the diagnostic work-up of patients with these diseases; here, we have tested the utility of high-throughput STELA (HT-STELA) for this purpose. HT-STELA was applied to a cohort of unaffected individuals (n = 171) and a retrospective cohort of mutation carriers (n = 172).

View Article and Find Full Text PDF

Identifying attributes that distinguish pre-malignant from senescent cells provides opportunities for targeted disease eradication and revival of anti-tumour immunity. We modelled a telomere-driven crisis in four human fibroblast lines, sampling at multiple time points to delineate genomic rearrangements and transcriptome developments that characterize the transition from dynamic proliferation into replicative crisis. Progression through crisis was associated with abundant intra-chromosomal telomere fusions with increasing asymmetry and reduced microhomology usage, suggesting shifts in DNA repair capacity.

View Article and Find Full Text PDF